首页 > 最新文献

Biomedical Photonics最新文献

英文 中文
Photodynamic therapy in the treatment of HPV-associated cervical cancer: mechanisms, challenges and future prospects 治疗人乳头瘤病毒相关宫颈癌的光动力疗法:机制、挑战和未来前景
Q3 Medicine Pub Date : 2024-05-17 DOI: 10.24931/2413-9432-2023-13-1-47-55
N. А. Shanazarov, S. V. Zinchenko, S. D. Kisikova, A. A. Rizvanov, S. Smailova, K. A. Petukhov, Zh. Zh. Salmaganbetova
Photodynamic therapy (PDT) has shown promise as a modality for the treatment of cervical cancer caused by the human papillomavirus (HPV). This review provides a comprehensive examination of the role of PDT in overcoming the challenges presented by conventional treatments for cervical cancer. Beginning with an overview of the relationship between cervical cancer and HPV infection, the review introduces the principles of PDT, its mechanism of action, and its potential as an innovative treatment strategy. The review highlights preclinical studies in animal models that demonstrate the efficacy of PDT in targeting HPV-infected cervical cells and provide mechanistic insights into its cytotoxic effects. We reviewed clinical studies and case reports highlighting the potential of PDT as an alternative or adjunctive treatment option. Challenges and limitations, including depth of light penetration, photosensitizer specificity, and standardization of protocols, will be discussed in the context of potential side effects and comparison with conventional treatments. Future directions include ongoing research, combination therapies with immunotherapy or targeted agents, advances in photosensitizer development, and personalized approaches. The advancement of PDT promises to change the landscape of HPV-associated cervical cancer treatment by providing a targeted, personalized, and minimally invasive approach.
光动力疗法(PDT)作为一种治疗由人类乳头瘤病毒(HPV)引起的宫颈癌的方法,已显示出良好的前景。本综述全面探讨了光动力疗法在克服宫颈癌传统治疗方法所带来的挑战方面的作用。综述首先概述了宫颈癌与 HPV 感染之间的关系,然后介绍了光动力疗法的原理、作用机制及其作为创新治疗策略的潜力。综述重点介绍了在动物模型中进行的临床前研究,这些研究证明了光动力疗法在靶向 HPV 感染的宫颈细胞方面的疗效,并从机理上揭示了其细胞毒性效应。我们回顾了临床研究和病例报告,强调了光动力疗法作为替代或辅助治疗方案的潜力。我们将结合潜在的副作用以及与传统治疗方法的比较,讨论其面临的挑战和局限性,包括光穿透深度、光敏剂特异性和方案的标准化。未来的发展方向包括正在进行的研究、与免疫疗法或靶向药物的联合疗法、光敏剂的开发进展以及个性化方法。光动力疗法的发展有望通过提供有针对性、个性化和微创的方法,改变 HPV 相关宫颈癌的治疗格局。
{"title":"Photodynamic therapy in the treatment of HPV-associated cervical cancer: mechanisms, challenges and future prospects","authors":"N. А. Shanazarov, S. V. Zinchenko, S. D. Kisikova, A. A. Rizvanov, S. Smailova, K. A. Petukhov, Zh. Zh. Salmaganbetova","doi":"10.24931/2413-9432-2023-13-1-47-55","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-13-1-47-55","url":null,"abstract":"Photodynamic therapy (PDT) has shown promise as a modality for the treatment of cervical cancer caused by the human papillomavirus (HPV). This review provides a comprehensive examination of the role of PDT in overcoming the challenges presented by conventional treatments for cervical cancer. Beginning with an overview of the relationship between cervical cancer and HPV infection, the review introduces the principles of PDT, its mechanism of action, and its potential as an innovative treatment strategy. The review highlights preclinical studies in animal models that demonstrate the efficacy of PDT in targeting HPV-infected cervical cells and provide mechanistic insights into its cytotoxic effects. We reviewed clinical studies and case reports highlighting the potential of PDT as an alternative or adjunctive treatment option. Challenges and limitations, including depth of light penetration, photosensitizer specificity, and standardization of protocols, will be discussed in the context of potential side effects and comparison with conventional treatments. Future directions include ongoing research, combination therapies with immunotherapy or targeted agents, advances in photosensitizer development, and personalized approaches. The advancement of PDT promises to change the landscape of HPV-associated cervical cancer treatment by providing a targeted, personalized, and minimally invasive approach.","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":"66 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140964876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photodynamic therapy of leukoplakia of the oral mucosa: experience of using method in 223 patients 口腔黏膜白斑病的光动力疗法:223 名患者的使用经验
Q3 Medicine Pub Date : 2024-05-16 DOI: 10.24931/2413-9432-2023-13-1-39-46
T. Artsemyeva, D. Tzerkovsky
The aim of this study was to analyze the immediate and long-term results of using photodynamic therapy (PDT) in patients with leukoplakia of the oral mucosa. The retrospective study included 223 patients with morphologically verified leukoplakia of the oral mucosa. Patients received treatment at the hyperthermia and photodynamic therapy department from 2013 to 2023. The average age was 51.9±8.9 years. Clinically, 211 patients (94.6%) had a flat form of the disease, 12 patients (5.4%) had a verrucous form. The photosensitizer (PS), based on chlorin e6, was administered intravenously once in doses of 1.7 to 2.5 mg/kg body weight. Irradiation of pathologically changed lesions was carried out 2-2.5 hours after the end of its infusion, using a semiconductor laser device “UPL PDT”, with a wavelength λ=665±5 nm. The laser radiation dose density varied from 25 to 100 J/cm², the power density from 0.07 to 0.32 W/cm², the duration of one irradiation field - from 2 to 13.5 minutes, depending on its linear dimensions. The severity of adverse reactions was assessed on days 1-30 after treatment using the CTCAE 4.03 scale. The immediate results of treatment were assessed up to 3 months after PDT, with morphological confirmation of the response to treatment. No serious adverse reactions were observed during PS infusion and irradiation. No symptoms of dermal phototoxicity were reported. During control examinations, up to 3 months after irradiation in patients with flat and verrucous forms, the frequency of complete regressions was 97.1% (n=205) and 58.3% (n=6) cases, partial regressions - 2,9% (n=7) and 25% (n=3) of cases, respectively. Objective response rates were observed at 100% and 83.3%, respectively. The period of observation of patients varies from 3 to 120 months. (average 66 months). The frequency of disease relapses during this period was 9%. Patients with partial regression and identified relapse were treated with repeated PDT sessions. PDT is a well-tolerated and effective treatment method for patients with leukoplakia of the oral mucosa, which has significant advantages over traditional methods of treating this precancerous pathology. These include minimal toxicity to the normal tissues surrounding the pathological foci due to the selective accumulation of PS in leukoplakia tissues, a slight risk of serious adverse reactions, the possibility of an outpatient session, the possibility of repeated treatment over a large area of damage and good cosmetic results).
本研究旨在分析对口腔黏膜白斑病患者使用光动力疗法(PDT)的近期和远期效果。这项回顾性研究包括 223 名经形态学验证的口腔黏膜白斑病患者。患者于 2013 年至 2023 年期间在热疗和光动力疗法科接受了治疗。平均年龄为(51.9±8.9)岁。临床上,211 名患者(94.6%)为扁平型口腔黏膜白斑,12 名患者(5.4%)为疣状口腔黏膜白斑。光敏剂(PS)基于氯素 e6,静脉注射一次,剂量为 1.7 至 2.5 毫克/千克体重。输注结束后 2-2.5 小时,使用波长为 λ=665±5 nm 的半导体激光设备 "UPL PDT "对病理变化的病灶进行照射。激光辐射剂量密度为 25 至 100 J/cm²,功率密度为 0.07 至 0.32 W/cm²,一个照射区域的持续时间为 2 至 13.5 分钟,具体取决于其线性尺寸。不良反应的严重程度在治疗后第 1-30 天使用 CTCAE 4.03 量表进行评估。对治疗的即时效果进行了评估,直至 PDT 治疗后 3 个月,并对治疗反应进行了形态学确认。在 PS 输注和照射过程中未观察到严重的不良反应。没有皮肤光毒性症状的报告。在对照组检查中,扁平疣和疣状疣患者在照射 3 个月后,完全消退的比例分别为 97.1%(205 例)和 58.3%(6 例),部分消退的比例分别为 2.9%(7 例)和 25%(3 例)。客观反应率分别为 100%和 83.3%。对患者的观察期从 3 个月到 120 个月不等。(平均 66 个月)。在此期间疾病复发的频率为 9%。部分消退和复发的患者接受了重复的光动力疗法治疗。对于口腔黏膜白斑病患者来说,光导光疗是一种耐受性良好且有效的治疗方法,与治疗这种癌前病变的传统方法相比具有显著优势。这些优势包括:由于 PS 在白斑组织中的选择性蓄积,对病灶周围正常组织的毒性极小;发生严重不良反应的风险较小;可在门诊进行治疗;可对大面积损害进行重复治疗;以及良好的美容效果)。
{"title":"Photodynamic therapy of leukoplakia of the oral mucosa: experience of using method in 223 patients","authors":"T. Artsemyeva, D. Tzerkovsky","doi":"10.24931/2413-9432-2023-13-1-39-46","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-13-1-39-46","url":null,"abstract":"The aim of this study was to analyze the immediate and long-term results of using photodynamic therapy (PDT) in patients with leukoplakia of the oral mucosa. The retrospective study included 223 patients with morphologically verified leukoplakia of the oral mucosa. Patients received treatment at the hyperthermia and photodynamic therapy department from 2013 to 2023. The average age was 51.9±8.9 years. Clinically, 211 patients (94.6%) had a flat form of the disease, 12 patients (5.4%) had a verrucous form. The photosensitizer (PS), based on chlorin e6, was administered intravenously once in doses of 1.7 to 2.5 mg/kg body weight. Irradiation of pathologically changed lesions was carried out 2-2.5 hours after the end of its infusion, using a semiconductor laser device “UPL PDT”, with a wavelength λ=665±5 nm. The laser radiation dose density varied from 25 to 100 J/cm², the power density from 0.07 to 0.32 W/cm², the duration of one irradiation field - from 2 to 13.5 minutes, depending on its linear dimensions. The severity of adverse reactions was assessed on days 1-30 after treatment using the CTCAE 4.03 scale. The immediate results of treatment were assessed up to 3 months after PDT, with morphological confirmation of the response to treatment. No serious adverse reactions were observed during PS infusion and irradiation. No symptoms of dermal phototoxicity were reported. During control examinations, up to 3 months after irradiation in patients with flat and verrucous forms, the frequency of complete regressions was 97.1% (n=205) and 58.3% (n=6) cases, partial regressions - 2,9% (n=7) and 25% (n=3) of cases, respectively. Objective response rates were observed at 100% and 83.3%, respectively. The period of observation of patients varies from 3 to 120 months. (average 66 months). The frequency of disease relapses during this period was 9%. Patients with partial regression and identified relapse were treated with repeated PDT sessions. PDT is a well-tolerated and effective treatment method for patients with leukoplakia of the oral mucosa, which has significant advantages over traditional methods of treating this precancerous pathology. These include minimal toxicity to the normal tissues surrounding the pathological foci due to the selective accumulation of PS in leukoplakia tissues, a slight risk of serious adverse reactions, the possibility of an outpatient session, the possibility of repeated treatment over a large area of damage and good cosmetic results).","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":"15 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140968926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photodynamic therapy in treatment of squamous cell carcinoma of oral cavity with chlorine e6 photosensitizer with long-term follow up 用氯e6光敏剂治疗口腔鳞状细胞癌的光动力疗法及长期随访
Q3 Medicine Pub Date : 2024-05-15 DOI: 10.24931/2413-9432-2023-13-1-28-38
Yury Panaseykin, V. Kapinus, E. Filonenko, V. Polkin, F. Sevrukov, M. A. Smirnova, P. Isaev, S. A. Ivanov, A. D. Kaprin
Photodynamic therapy is an effective method for treating superficial forms of malignant neoplasms, characterized by a minimal risk of damage to normal tissues. In this study, we presented our experience of treating cancer of the oral mucosa using photodynamic therapy, and analyzed the immediate and long-term results of treatment. 38 patients with squamous cell carcinoma of oral cavity mucosa, with a depth of invasion no more than 7 mm, were included in the study. All patients underwent photodynamic therapy with chlorine e6 based photosensitizer. Photosensitizers were administered intravenously 3 hours before irradiation, at a dosage of 1 mg/kg of the patient’s weight. Photodynamic therapy was performed with the following parameters: P – 1.0 W, Ps – 0.31 W/cm2, E – 300 J/cm2. The area of one irradiation field ranged 1.0-2.0 cm2. Treatment effect was evaluated by RECIST 1.1. Overall survival, cancer-specific survival, and disease-free survival were calculated using Kaplan-Meier curves. Evaluation of adverse events was made by .TCAE 5.0 criteria. At 35 (92.1%) out of 38 cases, complete regression was observed after photodynamic therapy. Among them in 3 out of 35 patients relapse was diagnosed in 11.5 to 43.2 months. The total number of patients who didn’t respond to treatment was 6 (15.8%). Follow-up period was 4.2-87.3 months. (mean 42.9). 34 (89.5%) out of 38 patients are alive, 1 (2.6%) died from progression, and three died from other causes. The 5-year overall survival rate was 82.1%, cancer-specific survival rate was 97.0%, and disease-free survival rate was 81.1%. Among the factors significantly (p < 0.05) influencing relapse-free survival: depth of invasion < 5 mm (p – 0.013) and the presence of leukoplakia (p – 0.007). When assessing cancer-specific survival, factors worsening the prognosis were: age >70 years (p – 0.034) and the presence of leukoplakia (p – 0.007). Photodynamic therapy is an alternative treatment method of oral cancer superficial lesions, in case of proper assessment of primary lesion and in case of possibility of full irradiation of the tumor. Moreover, after using photodynamic therapy, the underlying connective-muscular structures are preserved, which promotes rapid healing with minimal scarring, the functions of the affected organ remain intact, and cosmetic defects do not form.
光动力疗法是治疗浅表恶性肿瘤的有效方法,其特点是对正常组织的损伤风险极小。在这项研究中,我们介绍了使用光动力疗法治疗口腔黏膜癌的经验,并分析了治疗的近期和远期效果。研究共纳入了 38 名口腔黏膜鳞状细胞癌患者,侵犯深度不超过 7 毫米。所有患者都接受了基于氯e6光敏剂的光动力疗法。光敏剂在照射前 3 小时静脉注射,剂量为患者体重的 1 毫克/千克。光动力疗法的参数如下:P - 1.0 W,Ps - 0.31 W/cm2,E - 300 J/cm2。一个照射野的面积为 1.0-2.0 平方厘米。治疗效果根据 RECIST 1.1 进行评估。总生存率、癌症特异性生存率和无病生存率采用 Kaplan-Meier 曲线进行计算。不良反应评估采用.TCAE 5.0标准。在 38 例患者中,有 35 例(92.1%)在光动力治疗后完全消退。其中,35 例患者中有 3 例在 11.5 至 43.2 个月后复发。对治疗无效的患者共有 6 人(15.8%)。随访时间为 4.2-87.3 个月(平均 42.9 个月)。(平均 42.9 个月)。38名患者中有34人(89.5%)存活,1人(2.6%)死于病情恶化,3人死于其他原因。5年总生存率为82.1%,癌症特异性生存率为97.0%,无病生存率为81.1%。对无复发生存率有明显影响(p < 0.05)的因素包括:浸润深度小于 5 毫米(p - 0.013)和存在白斑(p - 0.007)。在评估癌症特异性生存率时,使预后恶化的因素有:年龄大于 70 岁(p - 0.034)和存在白斑(p - 0.007)。光动力疗法是治疗口腔癌表皮病变的一种替代方法,前提是对原发病灶进行适当评估,并有可能对肿瘤进行全面照射。此外,使用光动力疗法后,下层结缔组织肌肉结构得以保留,从而促进快速愈合,瘢痕最小,受影响器官的功能保持完好,也不会形成外观缺陷。
{"title":"Photodynamic therapy in treatment of squamous cell carcinoma of oral cavity with chlorine e6 photosensitizer with long-term follow up","authors":"Yury Panaseykin, V. Kapinus, E. Filonenko, V. Polkin, F. Sevrukov, M. A. Smirnova, P. Isaev, S. A. Ivanov, A. D. Kaprin","doi":"10.24931/2413-9432-2023-13-1-28-38","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-13-1-28-38","url":null,"abstract":"Photodynamic therapy is an effective method for treating superficial forms of malignant neoplasms, characterized by a minimal risk of damage to normal tissues. In this study, we presented our experience of treating cancer of the oral mucosa using photodynamic therapy, and analyzed the immediate and long-term results of treatment. 38 patients with squamous cell carcinoma of oral cavity mucosa, with a depth of invasion no more than 7 mm, were included in the study. All patients underwent photodynamic therapy with chlorine e6 based photosensitizer. Photosensitizers were administered intravenously 3 hours before irradiation, at a dosage of 1 mg/kg of the patient’s weight. Photodynamic therapy was performed with the following parameters: P – 1.0 W, Ps – 0.31 W/cm2, E – 300 J/cm2. The area of one irradiation field ranged 1.0-2.0 cm2. Treatment effect was evaluated by RECIST 1.1. Overall survival, cancer-specific survival, and disease-free survival were calculated using Kaplan-Meier curves. Evaluation of adverse events was made by .TCAE 5.0 criteria. At 35 (92.1%) out of 38 cases, complete regression was observed after photodynamic therapy. Among them in 3 out of 35 patients relapse was diagnosed in 11.5 to 43.2 months. The total number of patients who didn’t respond to treatment was 6 (15.8%). Follow-up period was 4.2-87.3 months. (mean 42.9). 34 (89.5%) out of 38 patients are alive, 1 (2.6%) died from progression, and three died from other causes. The 5-year overall survival rate was 82.1%, cancer-specific survival rate was 97.0%, and disease-free survival rate was 81.1%. Among the factors significantly (p < 0.05) influencing relapse-free survival: depth of invasion < 5 mm (p – 0.013) and the presence of leukoplakia (p – 0.007). When assessing cancer-specific survival, factors worsening the prognosis were: age >70 years (p – 0.034) and the presence of leukoplakia (p – 0.007). Photodynamic therapy is an alternative treatment method of oral cancer superficial lesions, in case of proper assessment of primary lesion and in case of possibility of full irradiation of the tumor. Moreover, after using photodynamic therapy, the underlying connective-muscular structures are preserved, which promotes rapid healing with minimal scarring, the functions of the affected organ remain intact, and cosmetic defects do not form.","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":" 58","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141128257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of silver nanoparticle and low-level laser on the immune response and healing of albino mice skin wounds 银纳米粒子和低强度激光对白化小鼠皮肤伤口的免疫反应和愈合的影响
Q3 Medicine Pub Date : 2024-05-11 DOI: 10.24931/2413-9432-2023-13-1-16-27
H. H. Soltan, A. Afifi, A. Mahmoud, M. Refaat, O. F. Al Balah
The structural integrity of the skin, which acts as a barrier to keep harmful external substances out of the body, is compromised by wounds. The process of wound healing is a multifaceted and ever-changing phenomenon that entails the replacement of bodily tissues or damaged skin. It has been demonstrated that nanoparticles, especially silver nanoparticles, have anti-microbial and anti-inflammatory qualities that encourage cell migration and proliferation. Low level laser therapy has the potential to accelerate wound healing by stimulating cell regeneration after injury, reducing pain, and modulating the immune system. The aim of our study is to evaluate the healing process after treatment with silver nanoparticle and/or low level laser by measuring the serum levels of some pro-inflammatory cytokines (IL1b, IL6, and TNF-α), wound healing rate and histological analysis. Wounds were inflicted into 63 adult male albino mice (Mus musculus) and randomly divided into nine groups (7 per each). Control was left to normal healing. Other groups received a different treatment with laser, silver nanoparticle or both for 21 days. Injured skin was sampled for histopathological examination. Quantitative determination of TNFα, IL1 beta and IL6 were carried out using the sandwich enzyme-linked immunosorbent assay (ELISA) twice (day 2 and day 21). One-way and two-way analysis of variance (ANOVA) was used for statistical analysis. The results showed that the groups treated with silver nanoparticles and / or low-level laser promoted wound healing by reducing pro- inflammatory cytokines (IL1β, IL6 and TNFα) and showed significantly better wound closure with a significant reduction in wound size. At day 2 histopathological changes were very similar in different groups. When silver nanoparticles were applied, either alone or in combination with laser exposure, better granulation tissue and fibrosis also necrosis in the canter of the lesion and high score of re-epithelialization with less inflammation observed gradually till day 21. The results of this study suggested that silver nanoparticles and low-level laser have a wound healing potential, since topical treatment with silver nanoparticles and low-level leasers has effectively improved the wound healing process.
皮肤是将外界有害物质阻挡在体外的屏障,其结构的完整性因伤口而受到损害。伤口愈合的过程是一个多方面的、不断变化的现象,需要替换身体组织或受损皮肤。研究表明,纳米粒子,尤其是纳米银粒子,具有抗微生物和消炎的特性,可促进细胞迁移和增殖。低水平激光疗法通过刺激受伤后的细胞再生、减轻疼痛和调节免疫系统,具有加速伤口愈合的潜力。我们的研究旨在通过测量血清中一些促炎细胞因子(IL1b、IL6 和 TNF-α)的水平、伤口愈合率和组织学分析,评估使用纳米银粒子和/或低强度激光治疗后的伤口愈合过程。将 63 只成年雄性白化小鼠(Mus musculus)的伤口随机分为 9 组(每组 7 只)。对照组保持正常愈合。其他各组分别接受激光、纳米银或两者的不同治疗,为期 21 天。受伤皮肤取样进行组织病理学检查。采用夹心酶联免疫吸附试验(ELISA)两次(第 2 天和第 21 天)定量检测 TNFα、IL1 beta 和 IL6。统计分析采用单因素和双因素方差分析(ANOVA)。结果表明,银纳米粒子和/或低强度激光治疗组通过减少促炎细胞因子(IL1β、IL6 和 TNFα)促进伤口愈合,伤口闭合情况明显改善,伤口面积显著缩小。第 2 天,不同组的组织病理学变化非常相似。当单独使用银纳米粒子或将其与激光照射结合使用时,肉芽组织和纤维化情况更好,病变部位的坏死情况也更好,直到第 21 天才逐渐观察到较高的再上皮化率和较少的炎症。这项研究结果表明,纳米银粒子和低强度激光具有愈合伤口的潜力,因为使用纳米银粒子和低强度激光进行局部治疗能有效改善伤口愈合过程。
{"title":"Effects of silver nanoparticle and low-level laser on the immune response and healing of albino mice skin wounds","authors":"H. H. Soltan, A. Afifi, A. Mahmoud, M. Refaat, O. F. Al Balah","doi":"10.24931/2413-9432-2023-13-1-16-27","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-13-1-16-27","url":null,"abstract":"The structural integrity of the skin, which acts as a barrier to keep harmful external substances out of the body, is compromised by wounds. The process of wound healing is a multifaceted and ever-changing phenomenon that entails the replacement of bodily tissues or damaged skin. It has been demonstrated that nanoparticles, especially silver nanoparticles, have anti-microbial and anti-inflammatory qualities that encourage cell migration and proliferation. Low level laser therapy has the potential to accelerate wound healing by stimulating cell regeneration after injury, reducing pain, and modulating the immune system. The aim of our study is to evaluate the healing process after treatment with silver nanoparticle and/or low level laser by measuring the serum levels of some pro-inflammatory cytokines (IL1b, IL6, and TNF-α), wound healing rate and histological analysis. Wounds were inflicted into 63 adult male albino mice (Mus musculus) and randomly divided into nine groups (7 per each). Control was left to normal healing. Other groups received a different treatment with laser, silver nanoparticle or both for 21 days. Injured skin was sampled for histopathological examination. Quantitative determination of TNFα, IL1 beta and IL6 were carried out using the sandwich enzyme-linked immunosorbent assay (ELISA) twice (day 2 and day 21). One-way and two-way analysis of variance (ANOVA) was used for statistical analysis. The results showed that the groups treated with silver nanoparticles and / or low-level laser promoted wound healing by reducing pro- inflammatory cytokines (IL1β, IL6 and TNFα) and showed significantly better wound closure with a significant reduction in wound size. At day 2 histopathological changes were very similar in different groups. When silver nanoparticles were applied, either alone or in combination with laser exposure, better granulation tissue and fibrosis also necrosis in the canter of the lesion and high score of re-epithelialization with less inflammation observed gradually till day 21. The results of this study suggested that silver nanoparticles and low-level laser have a wound healing potential, since topical treatment with silver nanoparticles and low-level leasers has effectively improved the wound healing process.","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":"117 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140987805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of 650 nm red laser photobiomodulation therapy to accelerate wound healing post tooth extraction 650 纳米红色激光光生物调节疗法对加速拔牙后伤口愈合的效果
Q3 Medicine Pub Date : 2024-05-10 DOI: 10.24931/2413-9432-2024-13-1-4-15
S. D. Astuti, R. Nashichah, P. Widiyanti, E. M. Setiawatie, M. S. Amir, A. Apsari, .. Widyastuti, E. Hermanto, Y. Susilo, A. K. Yaqubi, D.Z. I. Nurdin, N. Anuar
After tooth extraction, there can be consequences involving injury to the tissue surrounding the extracted tooth, which may lead to severe problems such as inflammation and infection. The wound healing process comprises inflammation, proliferation, and remodeling phases. Photobiomodulation is a therapy form that utilizes the interaction of a light source with tissue. This interaction can activate an increase in Adenosine Triphosphate (ATP), which subsequently triggers a chain reaction leading to the creation of new blood vessels and an increase in the number of fibroblasts. This study used a red laser light source with a power of 3.32 ± 0.01 mW, delivering a dose of 3.5 J to patients for extraction indications. The parameters observed included Interleukin 1_ (IL-1_), Prostaglandin E2 (PGE2), Human Beta defensin 2 (HBD2), and Gingival Index (GI). The results of testing saliva samples using the enzyme-linked immunosorbent test (ELISA) for the parameters IL-1_, PGE2, and HBD2 show a significant influence between the control and therapy groups. Meanwhile, GI revealed a significant influence of therapy on the wound-healing process. Using the Mann-Whitney U test, on day 1, the p-value was found to be 0.32, indicating no significant deference between the control and therapy groups. However, on the third day after the therapy was administered, the p-value was obtained as 0.01, signifying a significant deference between the control and therapy groups. On day 5, a p-value of 0.034 was obtained, signifying a significant deference between the control and therapy groups. Based on the research results, it can be observed that there is a decrease in the values of IL-1_, PGE2, HBD2, and GI. This indicates that local immune cells, including resident macrophages, are activated by pro-inflammatory mediators released in response to injury, and they play an essential role in accelerating wound healing.
拔牙后,拔牙周围的组织可能会受到损伤,从而导致炎症和感染等严重问题。伤口愈合过程包括炎症、增殖和重塑阶段。光生物调节是一种利用光源与组织相互作用的治疗方式。这种相互作用可激活三磷酸腺苷(ATP)的增加,进而引发连锁反应,导致新血管的生成和成纤维细胞数量的增加。这项研究使用了功率为 3.32 ± 0.01 mW 的红色激光光源,为患者提供 3.5 J 的剂量,用于提取适应症。观察到的参数包括白细胞介素 1_ (IL-1_)、前列腺素 E2 (PGE2)、人β防御素 2 (HBD2)和牙龈指数 (GI)。使用酶联免疫吸附试验(ELISA)对唾液样本中的 IL-1_、PGE2 和 HBD2 参数进行检测的结果显示,对照组和治疗组之间存在显著影响。同时,消化道指标显示治疗对伤口愈合过程有显著影响。通过 Mann-Whitney U 检验,发现在第 1 天,P 值为 0.32,表明对照组和治疗组之间没有显著差异。但在治疗后的第三天,P 值为 0.01,表明对照组和治疗组之间存在显著差异。第 5 天,P 值为 0.034,表明对照组和治疗组之间存在显著差异。根据研究结果可以看出,IL-1_、PGE2、HBD2 和 GI 的值都有所下降。这表明,包括常驻巨噬细胞在内的局部免疫细胞会被损伤时释放的促炎介质激活,它们在加速伤口愈合方面发挥着重要作用。
{"title":"Effectiveness of 650 nm red laser photobiomodulation therapy to accelerate wound healing post tooth extraction","authors":"S. D. Astuti, R. Nashichah, P. Widiyanti, E. M. Setiawatie, M. S. Amir, A. Apsari, .. Widyastuti, E. Hermanto, Y. Susilo, A. K. Yaqubi, D.Z. I. Nurdin, N. Anuar","doi":"10.24931/2413-9432-2024-13-1-4-15","DOIUrl":"https://doi.org/10.24931/2413-9432-2024-13-1-4-15","url":null,"abstract":"After tooth extraction, there can be consequences involving injury to the tissue surrounding the extracted tooth, which may lead to severe problems such as inflammation and infection. The wound healing process comprises inflammation, proliferation, and remodeling phases. Photobiomodulation is a therapy form that utilizes the interaction of a light source with tissue. This interaction can activate an increase in Adenosine Triphosphate (ATP), which subsequently triggers a chain reaction leading to the creation of new blood vessels and an increase in the number of fibroblasts. This study used a red laser light source with a power of 3.32 ± 0.01 mW, delivering a dose of 3.5 J to patients for extraction indications. The parameters observed included Interleukin 1_ (IL-1_), Prostaglandin E2 (PGE2), Human Beta defensin 2 (HBD2), and Gingival Index (GI). The results of testing saliva samples using the enzyme-linked immunosorbent test (ELISA) for the parameters IL-1_, PGE2, and HBD2 show a significant influence between the control and therapy groups. Meanwhile, GI revealed a significant influence of therapy on the wound-healing process. Using the Mann-Whitney U test, on day 1, the p-value was found to be 0.32, indicating no significant deference between the control and therapy groups. However, on the third day after the therapy was administered, the p-value was obtained as 0.01, signifying a significant deference between the control and therapy groups. On day 5, a p-value of 0.034 was obtained, signifying a significant deference between the control and therapy groups. Based on the research results, it can be observed that there is a decrease in the values of IL-1_, PGE2, HBD2, and GI. This indicates that local immune cells, including resident macrophages, are activated by pro-inflammatory mediators released in response to injury, and they play an essential role in accelerating wound healing.","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":" 31","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140991728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photodynamic therapy for a patient with basal cell skin cancer of the lower eyelid (clinical case) 下眼睑基底细胞皮肤癌患者的光动力疗法(临床病例)
Q3 Medicine Pub Date : 2024-03-07 DOI: 10.24931/2413-9432-2023-12-4-30-32
E. Filonenko, N. I. Grigoryevykh
The article provides an example of successful treatment of a patient with basal cell skin cancer of the lower eyelid of the right eye, stage IB cT2aN0M0, with the presence of concomitant pathology – a decrease in the activity of plasma factor XII of blood coagulation (Hageman disease). The patient’s medical history is associated with long-term ineffective treatment of the tumor with Curaderm ointment. After diagnosis and further examination at the Moscow Research Institute named after. P.A. Herzen, at the Center for Laser and Photodynamic Diagnostics and Therapy of Tumors, the patient underwent organ-preserving treatment using photodynamic therapy. 1 course of photodynamic therapy with the photosensitizer chlorin e6 was carried out. Complete tumor regression was obtained; relapse-free follow-up period was 1 year
文章提供了一个成功治疗右眼下眼睑基底细胞皮肤癌(IB cT2aN0M0 期)患者的实例,该患者同时伴有血浆凝血因子 XII 活性降低(哈格曼病)的病理改变。患者的病史与长期使用 Curaderm 软膏治疗肿瘤无效有关。在以 P.A. Herzen 命名的莫斯科研究所进行诊断和进一步检查后,他被诊断为 "哈格曼病"。P.A.赫尔岑命名的莫斯科研究所的肿瘤激光和光动力诊断与治疗中心进行诊断和进一步检查后,患者接受了光动力疗法的器官保留治疗。使用光敏剂氯素 e6 进行了一个疗程的光动力治疗。肿瘤完全消退;无复发随访期为 1 年
{"title":"Photodynamic therapy for a patient with basal cell skin cancer of the lower eyelid (clinical case)","authors":"E. Filonenko, N. I. Grigoryevykh","doi":"10.24931/2413-9432-2023-12-4-30-32","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-12-4-30-32","url":null,"abstract":"The article provides an example of successful treatment of a patient with basal cell skin cancer of the lower eyelid of the right eye, stage IB cT2aN0M0, with the presence of concomitant pathology – a decrease in the activity of plasma factor XII of blood coagulation (Hageman disease). The patient’s medical history is associated with long-term ineffective treatment of the tumor with Curaderm ointment. After diagnosis and further examination at the Moscow Research Institute named after. P.A. Herzen, at the Center for Laser and Photodynamic Diagnostics and Therapy of Tumors, the patient underwent organ-preserving treatment using photodynamic therapy. 1 course of photodynamic therapy with the photosensitizer chlorin e6 was carried out. Complete tumor regression was obtained; relapse-free follow-up period was 1 year","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":"8 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140260304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern diagnostic technologies in oncodermatology 肿瘤皮肤科的现代诊断技术
Q3 Medicine Pub Date : 2024-03-07 DOI: 10.24931/2413-9432-2023-12-4-4-14
E. Filonenko, A. D. Kaprin
Skin tumors occupy the first place in terms of incidence in the structure of oncological neoplasms. The WHO estimates that 60,000 people die each year from malignant neoplasms of the skin: 48,000 from melanoma and 12,000 from skin cancer. Timely diagnosis of skin cancer makes it possible to achieve a cure for cancer patients with long periods of relapse-free follow-up after the completion of specialized treatment. The introduction of high-tech optical methods for diagnosing skin neoplasms into clinical practice has significantly increased the specificity, sensitivity, and accuracy of diagnostics. The review is devoted to a discussion of such methods for diagnosing skin neoplasms as fluorescent diagnostics, digital dermatoscopy, SIA-scopy, and confocal microscopy. The features of the application of each of the methods are discussed, the results of the most significant Russian and foreign studies in this field are presented, as well as our own results of the practical application of a number of high-tech optical diagnostic methods at the P.A. Herzen Moscow Oncology Research Center
在肿瘤结构中,皮肤肿瘤的发病率居首位。据世界卫生组织估计,每年有 6 万人死于皮肤恶性肿瘤:其中 48 000 人死于黑色素瘤,12 000 人死于皮肤癌。对皮肤癌的及时诊断使癌症患者在完成专业治疗后获得长期无复发随访的治愈成为可能。将诊断皮肤肿瘤的高科技光学方法引入临床实践,大大提高了诊断的特异性、灵敏度和准确性。本综述专门讨论了荧光诊断、数字皮肤镜、SIA-scopy 和共聚焦显微镜等诊断皮肤肿瘤的方法。文中讨论了每种方法的应用特点,介绍了俄罗斯和国外在这一领域最重要的研究成果,以及我们自己在 P.A. Herzen 莫斯科肿瘤学研究中心实际应用一些高科技光学诊断方法的结果。
{"title":"Modern diagnostic technologies in oncodermatology","authors":"E. Filonenko, A. D. Kaprin","doi":"10.24931/2413-9432-2023-12-4-4-14","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-12-4-4-14","url":null,"abstract":"Skin tumors occupy the first place in terms of incidence in the structure of oncological neoplasms. The WHO estimates that 60,000 people die each year from malignant neoplasms of the skin: 48,000 from melanoma and 12,000 from skin cancer. Timely diagnosis of skin cancer makes it possible to achieve a cure for cancer patients with long periods of relapse-free follow-up after the completion of specialized treatment. The introduction of high-tech optical methods for diagnosing skin neoplasms into clinical practice has significantly increased the specificity, sensitivity, and accuracy of diagnostics. The review is devoted to a discussion of such methods for diagnosing skin neoplasms as fluorescent diagnostics, digital dermatoscopy, SIA-scopy, and confocal microscopy. The features of the application of each of the methods are discussed, the results of the most significant Russian and foreign studies in this field are presented, as well as our own results of the practical application of a number of high-tech optical diagnostic methods at the P.A. Herzen Moscow Oncology Research Center","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":"13 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140259951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomical-functional state of surface lymphatic system of lower extremities in chronic vein diseases according to fluorescence lymphograph 荧光淋巴管图显示慢性静脉疾病患者下肢表面淋巴系统的解剖功能状态
Q3 Medicine Pub Date : 2024-03-07 DOI: 10.24931/2413-9432-2023-12-4-15-21
Kh. A. Abduvosidov, S. M. Chudnykh, V. G. Shestakova, A. G. Alekseev, M. M. Kokoev, N. S. Kozlov, G. M. Korolyuk
Despite the large arsenal of diagnostic methods for studying the lymphatic system, there are isolated works on its morpho-functional state in chronic venous insufluciency. The purpose of the study was to study the anatomical and physiological state of the surface lymphatic system of the lower extremities in persons with different clinical classes of chronic vein diseases using fluorescence lifography. The study was conducted in 105 patients divided into six groups according to the clinical class of chronic diseases of the veins of the lower extremities according to the CEAP classiffication. We used fluorescent lymphography using sodium fluorescein to study the anatomical and functional capabilities of the lymphotone. The study revealed that morphofunctional changes in superficial lymphatic vessels in chronic lower extremity vein diseases depend on venous system decompensation. With an increase in the clinical class of chronic diseases of the veins of the lower extremities, the rate of lymph flow through the superficial lymphatic vessels is statistically significantly reduced. At the same time, the antegrade lymph cell is completely absent in С5-С6, with the appearance of retrograde outflow and discharge of the lymph into the deep lymph vessels. Thus, the progression of chronic venous insufficiency leads to proportional progression of morphofunctional changes in the superficial lymphatic system, which leads to the formation of lymphovenous insufficiency.
尽管研究淋巴系统的诊断方法种类繁多,但有关慢性静脉功能不全患者淋巴系统形态和功能状态的研究却鲜有问世。本研究的目的是利用荧光生命图谱研究不同临床级别的慢性静脉疾病患者下肢表面淋巴系统的解剖和生理状态。研究根据 CEAP 分级,按照下肢静脉慢性疾病的临床分级将 105 名患者分为六组。我们使用荧光素钠荧光淋巴造影来研究淋巴管的解剖和功能能力。研究显示,慢性下肢静脉疾病患者浅表淋巴管的形态功能变化取决于静脉系统的失代偿。据统计,随着下肢静脉慢性疾病临床分级的增加,通过浅表淋巴管的淋巴流量明显减少。同时,在С5-С6中,前行淋巴细胞完全消失,出现逆行流出,淋巴排入深层淋巴管。因此,慢性静脉功能不全的进展会导致浅表淋巴系统形态功能变化的成比例进展,从而形成淋巴-静脉功能不全。
{"title":"Anatomical-functional state of surface lymphatic system of lower extremities in chronic vein diseases according to fluorescence lymphograph","authors":"Kh. A. Abduvosidov, S. M. Chudnykh, V. G. Shestakova, A. G. Alekseev, M. M. Kokoev, N. S. Kozlov, G. M. Korolyuk","doi":"10.24931/2413-9432-2023-12-4-15-21","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-12-4-15-21","url":null,"abstract":"Despite the large arsenal of diagnostic methods for studying the lymphatic system, there are isolated works on its morpho-functional state in chronic venous insufluciency. The purpose of the study was to study the anatomical and physiological state of the surface lymphatic system of the lower extremities in persons with different clinical classes of chronic vein diseases using fluorescence lifography. The study was conducted in 105 patients divided into six groups according to the clinical class of chronic diseases of the veins of the lower extremities according to the CEAP classiffication. We used fluorescent lymphography using sodium fluorescein to study the anatomical and functional capabilities of the lymphotone. The study revealed that morphofunctional changes in superficial lymphatic vessels in chronic lower extremity vein diseases depend on venous system decompensation. With an increase in the clinical class of chronic diseases of the veins of the lower extremities, the rate of lymph flow through the superficial lymphatic vessels is statistically significantly reduced. At the same time, the antegrade lymph cell is completely absent in С5-С6, with the appearance of retrograde outflow and discharge of the lymph into the deep lymph vessels. Thus, the progression of chronic venous insufficiency leads to proportional progression of morphofunctional changes in the superficial lymphatic system, which leads to the formation of lymphovenous insufficiency.","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":"18 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140261078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photodynamic therapy of Bowen’s disease 鲍温氏病的光动力疗法
Q3 Medicine Pub Date : 2024-03-07 DOI: 10.24931/2413-9432-2023-12-4-22-29
E. Filonenko, V. Ivanova-Radkevich
Bowen’s disease is a form of non-invasive (in situ) squamous cell skin cancer localized in the non-genital area. Russian and European clinical guidelines include photodynamic therapy (PDT) in the standard of care for patients with Bowen’s disease. In the present review, the efficacy and safety profile of different PDT regimens for Bowen’s disease are analyzed according to the available literature data. PDT can be used to treat large Bowen’s disease lesions localized in areas of the body characterized by severe healing and in cases where surgery is not feasible. Analysis of the results of studies shows that PDT is superior in efficacy and cosmetic results to traditional local treatments such as 5-fluorouracil or cryotherapy. In all analyzed studies in patients with Bowen’s disease, PDT achieved a significant clinical effect. Complete regression of pathologic foci was achieved in 67-100% of patients. In studies evaluating the recurrence rate of Bowen’s disease after PDT, this value ranged from 2-28% with the range of 6-18% in most of the studies. Most often, 5-aminolevulinic acid and its methyl ester are used for PDT in Bowen’s disease. According to some researchers, aminolevulinic acid allows to achieve a more long-term positive clinical effect with a lower incidence of painful reactions during treatment
鲍温氏病是一种非生殖器部位的非侵入性(原位)鳞状细胞皮肤癌。俄罗斯和欧洲的临床指南将光动力疗法(PDT)列为鲍温病患者的标准治疗方法。在本综述中,根据现有文献数据分析了不同光动力疗法治疗鲍温氏病的疗效和安全性。光导光疗可用于治疗大面积鲍温氏病病灶,这些病灶位于身体愈合严重的部位,而且无法进行手术治疗。对研究结果的分析表明,PDT 在疗效和美容效果方面均优于传统的局部治疗方法,如 5-氟尿嘧啶或冷冻疗法。在所有针对鲍温病患者的分析研究中,PDT 都取得了显著的临床效果。67%-100%的患者病灶完全消退。在评估光动力疗法后鲍温氏病复发率的研究中,复发率为 2%-28%,大多数研究的复发率为 6%-18%。大多数情况下,5-氨基乙酰丙酸及其甲酯被用于治疗鲍温氏病的光动力疗法。一些研究人员认为,氨基乙酰丙酸可获得更长期的积极临床效果,同时降低治疗过程中疼痛反应的发生率。
{"title":"Photodynamic therapy of Bowen’s disease","authors":"E. Filonenko, V. Ivanova-Radkevich","doi":"10.24931/2413-9432-2023-12-4-22-29","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-12-4-22-29","url":null,"abstract":"Bowen’s disease is a form of non-invasive (in situ) squamous cell skin cancer localized in the non-genital area. Russian and European clinical guidelines include photodynamic therapy (PDT) in the standard of care for patients with Bowen’s disease. In the present review, the efficacy and safety profile of different PDT regimens for Bowen’s disease are analyzed according to the available literature data. PDT can be used to treat large Bowen’s disease lesions localized in areas of the body characterized by severe healing and in cases where surgery is not feasible. Analysis of the results of studies shows that PDT is superior in efficacy and cosmetic results to traditional local treatments such as 5-fluorouracil or cryotherapy. In all analyzed studies in patients with Bowen’s disease, PDT achieved a significant clinical effect. Complete regression of pathologic foci was achieved in 67-100% of patients. In studies evaluating the recurrence rate of Bowen’s disease after PDT, this value ranged from 2-28% with the range of 6-18% in most of the studies. Most often, 5-aminolevulinic acid and its methyl ester are used for PDT in Bowen’s disease. According to some researchers, aminolevulinic acid allows to achieve a more long-term positive clinical effect with a lower incidence of painful reactions during treatment","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":"13 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140259956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical case of successful application of photodynamic therapy in advanced vulvar cancer 光动力疗法在晚期外阴癌中的成功应用
Q3 Medicine Pub Date : 2023-10-23 DOI: 10.24931/2413-9432-2023-12-3-21-24
N. A. Shanazarov, T. G. Grishachevа, G. S. Aldabergen, S. B. Smailova, Zh. Zh. Salmaganbetova
A significant therapeutic effect of photodynamic therapy (PDT) is shown in a patient with extensive vulvar cancer after ineffective surgical and chemoradiotherapy. During the year, three courses of local PDT with a photosensitizer based on chlorin e6 were carried out. The photosensitizer was administered intravenously three hours before irradiation at a dose of 1.2 mg/kg. For laser irradiation (662 nm) of the vulvar tumor, a light guide for external irradiation was used: the power density was 0.2 W/cm 2 , the light dose was from 100 to 250 J/cm 2 . As a result of treatment, tumor regression and stable remission are observed. The patient remains under observation.
光动力疗法(PDT)对一例手术和放化疗无效的广泛性外阴癌患者的治疗效果显著。年内,进行了三个疗程的本地PDT,使用基于氯e6的光敏剂。光敏剂在照射前3小时静脉注射,剂量为1.2 mg/kg。外阴肿瘤激光照射(662 nm)采用外照射光导,功率密度为0.2 W/cm 2,光剂量为100 ~ 250 J/cm 2。治疗后,观察到肿瘤消退和稳定缓解。病人仍在观察中。
{"title":"Clinical case of successful application of photodynamic therapy in advanced vulvar cancer","authors":"N. A. Shanazarov, T. G. Grishachevа, G. S. Aldabergen, S. B. Smailova, Zh. Zh. Salmaganbetova","doi":"10.24931/2413-9432-2023-12-3-21-24","DOIUrl":"https://doi.org/10.24931/2413-9432-2023-12-3-21-24","url":null,"abstract":"A significant therapeutic effect of photodynamic therapy (PDT) is shown in a patient with extensive vulvar cancer after ineffective surgical and chemoradiotherapy. During the year, three courses of local PDT with a photosensitizer based on chlorin e6 were carried out. The photosensitizer was administered intravenously three hours before irradiation at a dose of 1.2 mg/kg. For laser irradiation (662 nm) of the vulvar tumor, a light guide for external irradiation was used: the power density was 0.2 W/cm 2 , the light dose was from 100 to 250 J/cm 2 . As a result of treatment, tumor regression and stable remission are observed. The patient remains under observation.","PeriodicalId":37713,"journal":{"name":"Biomedical Photonics","volume":"50 7","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135414384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Photonics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1